Osteolytic Lesion in PAPA Syndrome Responding to Anti-interleukin 1 Treatment

被引：24
|
作者：
Caorsi, Roberta
Picco, Paolo
Buoncompagni, Antonella
Martini, Alberto
Gattorno, Marco
机构：
[1] Ist Giannina Gaslini, Unita Operat Pediat 2, I-16147 Genoa, Italy
[2] Univ Genoa, Dept Pediat, Genoa, Italy
来源：
JOURNAL OF RHEUMATOLOGY | 2014年 / 41卷 / 11期
关键词：
RECURRENT MULTIFOCAL OSTEOMYELITIS; AUTOINFLAMMATORY DISORDER; MAJEED-SYNDROME; MUTATIONS;
D O I：
10.3899/jrheum.140060
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2333 / 2334
页数：2
相关论文
共 50 条
  • [21] Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition
    Napolitano, M.
    Megna, M.
    Fabbrocini, G.
    Nistico, S. P.
    Balato, N.
    Dastoli, S.
    Patruno, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (03) : 604 - 606
  • [22] ANTI-INTERLEUKIN 5 THERAPY FOR REFRACTORY EOSINOPHILIC GRANULOMATOSIS WITH POLYANGITIS AND HYPEREOSINOPHILIC SYNDROME OVERLAP
    McKernan, A.
    Wild, L.
    Le, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S119 - S119
  • [23] Anti-interleukin 33 treatment alleviates psoriatic dermatitis in mice induced imiquimod
    Fu, Dandan
    Zheng, Shuting
    Li, Jialin
    Hu, Hua
    Wang, Qingqing
    Fu, Xiuyu
    Li, Min
    Yan, Dong
    Yang, Zishan
    Tian, Zhongwei
    Song, Xiangfeng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 121
  • [24] Anti-interleukin 6 receptor therapy as rescue treatment for giant cell arteritis
    Beyer, Christian
    Axmann, Roland
    Sahinbegovic, Enijad
    Distler, Joerg H.
    Manger, Bernhard
    Schett, Georg
    Zwerina, Jochen
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (10) : 1874 - 1875
  • [25] Identification of a Homozygous PSTPIP1 Mutation in a Patient With a PAPA-Like Syndrome Responding to Canakinumab Treatment
    Geusau, Alexandra
    Mothes-Luksch, Nadine
    Nahavandi, Hesam
    Pickl, Winfried F.
    Wise, Carol A.
    Pourpak, Zahra
    Ponweiser, Elisabeth
    Eckhart, Leopold
    Sunder-Plassmann, Raute
    JAMA DERMATOLOGY, 2013, 149 (02) : 209 - 215
  • [26] Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab
    Ogata, Atsushi
    Morishima, Atsuyoshi
    Hirano, Toru
    Hishitani, Yoshihiro
    Hagihara, Keisuke
    Shima, Yoshihito
    Narazaki, Masashi
    Tanaka, Toshio
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (06) : 1164 - 1165
  • [27] Anti-interleukin (IL) 5 but not anti-IgE treatment prevents airway inflammation and hyperresponsiveness (AHR).
    Hamelmann, E
    Cieslewicz, G
    Joetham, A
    Schwarze, J
    Gelfand, EW
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 488 - 488
  • [28] PReS-FINAL-1005: Hypertransaminasemia in systemic juvenile idiopathic arthritis during anti-interleukin 1 treatment
    MI Gonzalez Fernandez
    R Bou
    R Silvia
    E Iglesias
    J Sánchez
    V Torrente
    J Antón
    Pediatric Rheumatology, 11 (Suppl 2)
  • [29] Treatment with Anti-Interleukin 23 Antibody Ameliorates Disease in Lupus-Prone Mice
    Kyttaris, Vasileios C.
    Kampagianni, Ourania
    Tsokos, George C.
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [30] Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice
    Fuss, IJ
    Marth, T
    Neurath, MF
    Pearlstein, GR
    Jain, A
    Strober, W
    GASTROENTEROLOGY, 1999, 117 (05) : 1078 - 1088
12345